BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lucendo AJ, Arias-González L, Molina-Infante J, Arias Á. Systematic review: health-related quality of life in children and adults with eosinophilic oesophagitis-instruments for measurement and determinant factors. Aliment Pharmacol Ther 2017;46:401-9. [PMID: 28639700 DOI: 10.1111/apt.14194] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Dhar A, Haboubi HN, Attwood SE, Auth MKH, Dunn JM, Sweis R, Morris D, Epstein J, Novelli MR, Hunter H, Cordell A, Hall S, Hayat JO, Kapur K, Moore AR, Read C, Sami SS, Turner PJ, Trudgill NJ. British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut 2022:gutjnl-2022-327326. [PMID: 35606089 DOI: 10.1136/gutjnl-2022-327326] [Reference Citation Analysis]
2 Lucendo AJ. Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies. Expert Rev Clin Immunol 2020;16:63-77. [PMID: 31842634 DOI: 10.1080/1744666X.2019.1705784] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Tamarit-sebastian S, Ferrer-soler FM, Lucendo AJ. Current options and investigational drugs for the treatment of eosinophilic esophagitis. Expert Opinion on Investigational Drugs. [DOI: 10.1080/13543784.2022.2033207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lucendo AJ, Miehlke S, Schlag C, Vieth M, von Arnim U, Molina-infante J, Hartmann D, Bredenoord AJ, Ciriza de los Rios C, Schubert S, Brückner S, Madisch A, Hayat J, Tack J, Attwood S, Mueller R, Greinwald R, Schoepfer A, Straumann A, Tack J, Vanuytsel T, Louis H, Musala C, Miehlke S, Frederking D, Bajbouj M, Schlag C, Nennstiel S, Brückner S, Schmelz R, Heimerl S, Stephan A, Fibbe C, Liedtke (née Laschinsky) N, Keller J, Rosien U, Haag S, Schneider A, Hartmann D, Schmöcker C, Buchholz H, Lammert F, Casper M, Reichert M, Madisch A, Sommer D, Mönnikes H, Stengel M, Schmidtmann M, Müller M, Eckardt A, Wehrmann T, Schubert S, Armerding P, Hofmann WP, Liceni T, von Arnim U, Kandulski A, Weigt J, Börner N, Lutz-vorderbrügge A, Albert J, Zeuzem S, Blumenstein I, Sprinzl K, Hausmann J, Bredenoord A, Bredenoord A, Warners M, Villarin AL, Arias ÁA, Tejero Bustos MÁ, Carrillo Ramos MJ, Olalla Gallardo JM, Tosina RJ, Molina-infante J, Zamorano J, Vaquero CS, Francés SC, Pérez T, Rodriguez T, Ciriza de los Ríos C, Rodríguez-valcárcel FC, Castel de Lucas I, Juan AP, Barenys M, Pons C, Martinez IP, Lauret ME, García AC, Rubio E, Straumann A, Hruz P, Brunner S, Hayat J, Poullis A. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial. Gastroenterology 2019;157:74-86.e15. [DOI: 10.1053/j.gastro.2019.03.025] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 21.0] [Reference Citation Analysis]
5 Munoz-Persy M, Lucendo AJ. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach. Eur J Pediatr 2018;177:649-63. [PMID: 29549437 DOI: 10.1007/s00431-018-3129-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
6 Miehlke S, von Arnim U, Schlag C, Labenz J, Madisch A. [Treatment of eosinophilic esophagitis - advancements and perspectives]. Z Gastroenterol 2021;59:869-78. [PMID: 34157757 DOI: 10.1055/a-1429-4192] [Reference Citation Analysis]
7 Peterson K, Lin E, Saffari H, Qeadan F, Pyne A, Firszt R, Robson J, Gleich G. Food-specific antibodies in oesophageal secretions: association with trigger foods in eosinophilic oesophagitis. Aliment Pharmacol Ther 2020;52:997-1007. [PMID: 32749744 DOI: 10.1111/apt.15879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Shillitoe B, Lee JC, Hussien M, Beintaris I, Stothard M, Johnston M, Dallal HJ, Michaelis LJ, Attwood S, Dhar A. Clinical spectrum of paediatric and adult eosinophilic oesophagitis in the North East of England from 2016 to 2019. Frontline Gastroenterol 2022;13:231-6. [DOI: 10.1136/flgastro-2021-101814] [Reference Citation Analysis]
9 Lucendo AJ. Nutritional approach to eosinophilic esophagitis: which diet and when. Minerva Gastroenterol (Torino) 2022;68:49-59. [PMID: 33267566 DOI: 10.23736/S2724-5985.20.02797-X] [Reference Citation Analysis]
10 Laserna-Mendieta EJ, Casabona S, Guagnozzi D, Savarino E, Perelló A, Guardiola-Arévalo A, Barrio J, Pérez-Martínez I, Lund Krarup A, Alcedo J, de la Riva S, Rey-Iborra E, Santander C, Arias Á, Lucendo AJ; EUREOS EoE CONNECT Research group. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry. Aliment Pharmacol Ther 2020;52:798-807. [PMID: 32677040 DOI: 10.1111/apt.15957] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 15.0] [Reference Citation Analysis]
11 Lucendo AJ, Molina-infante J. Esofagitis eosinofílica: diagnóstico y tratamiento actual basado en la evidencia. Gastroenterología y Hepatología 2018;41:281-91. [DOI: 10.1016/j.gastrohep.2017.12.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Miehlke S, Schlag C, Lucendo AJ, Biedermann L, Vaquero CS, Schmoecker C, Hayat J, Hruz P, Ciriza de Los Rios C, Bredenoord AJ, Vieth M, Schoepfer A, Attwood S, Mueller R, Burrack S, Greinwald R, Straumann A; International EOS-2 Study Group. Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme. United European Gastroenterol J 2022;10:330-43. [PMID: 35412032 DOI: 10.1002/ueg2.12220] [Reference Citation Analysis]
13 Cavalli E, Brusaferro A, Pieri ES, Cozzali R, Farinelli E, De' Angelis GL, Esposito S. Eosinophilic esophagitis in children: doubts and future perspectives. J Transl Med 2019;17:262. [PMID: 31399124 DOI: 10.1186/s12967-019-2014-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Lucendo AJ, Molina-infante J. Dietary therapy for eosinophilic esophagitis: chances and limitations in the clinical practice. Expert Review of Gastroenterology & Hepatology 2020;14:941-52. [DOI: 10.1080/17474124.2020.1791084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Lucendo AJ, Santander C, Savarino E, Guagnozzi D, Pérez-martínez I, Perelló A, Guardiola-arévalo A, Barrio J, Elena Betoré-glaria M, Gutiérrez-junquera C, Ciriza de los Ríos C, Racca F, Fernández-fernández S, Blas-jhon L, Lund Krarup A, de la Riva S, Naves JE, Carrión S, Rodríguez Oballe JA, García-morales N, Tamarit-sebastián S, Navarro P, Arias Á, Laserna-mendieta EJ, Casabona-francés S, Pérez-fernández T, Llerena Castro R, Ghisa M, Manie D, Pellegatta G, Suárez A, Alcedo J, Gil Simón P, Teresa Palomeque M, Asensio T, Granja-navacerrada A, de Mendoza Guena LH, Rodríguez Sánchez A, Masiques Mas L, Dainese R, Feo-ortega S. EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe. Therap Adv Gastroenterol 2022;15:175628482210742. [DOI: 10.1177/17562848221074204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Lucendo AJ, Molina-infante J. Treatment of eosinophilic esophagitis with diets. Minerva Gastroenterol Dietol 2020;66. [DOI: 10.23736/s1121-421x.19.02634-5] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Lucendo AJ. Drug treatment strategies for eosinophilic esophagitis in adults. Expert Opin Pharmacother 2022;:1-14. [PMID: 35379069 DOI: 10.1080/14656566.2022.2060077] [Reference Citation Analysis]
18 Miehlke S, Lucendo AJ, Straumann A, Jan Bredenoord A, Attwood S. Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence. Therap Adv Gastroenterol 2020;13:1756284820927282. [PMID: 32565912 DOI: 10.1177/1756284820927282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
19 Nennstiel S, Schlag C. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids. World J Gastroenterol 2020; 26(36): 5395-5407 [PMID: 33024392 DOI: 10.3748/wjg.v26.i36.5395] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Laserna-Mendieta EJ, Casabona S, Savarino E, Perelló A, Pérez-Martínez I, Guagnozzi D, Barrio J, Guardiola A, Asensio T, de la Riva S, Ruiz-Ponce M, Rodríguez-Oballe JA, Santander C, Arias Á, Lucendo AJ; EUREOS EoE CONNECT research group. Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice. Clin Gastroenterol Hepatol 2020;18:2903-2911.e4. [PMID: 31988045 DOI: 10.1016/j.cgh.2020.01.024] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 15.0] [Reference Citation Analysis]
21 Feo-ortega S, Lucendo AJ. Evidence-based treatments for eosinophilic esophagitis: insights for the clinician. Therap Adv Gastroenterol 2022;15:175628482110686. [DOI: 10.1177/17562848211068665] [Reference Citation Analysis]
22 Liu X, Xiao X, Liu D, Tan C. A meta-analysis on randomized controlled trials of treating eosinophilic esophagitis with budesonide. Ann Med 2022;54:2078-88. [PMID: 35862288 DOI: 10.1080/07853890.2022.2101689] [Reference Citation Analysis]
23 Rossetti D, Isoldi S, Oliva S. Eosinophilic Esophagitis: Update on Diagnosis and Treatment in Pediatric Patients. Paediatr Drugs 2020;22:343-56. [PMID: 32519266 DOI: 10.1007/s40272-020-00398-z] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Straumann A, Lucendo AJ, Miehlke S, Vieth M, Schlag C, Biedermann L, Vaquero CS, Ciriza de Los Rios C, Schmoecker C, Madisch A, Hruz P, Hayat J, von Arnim U, Bredenoord AJ, Schubert S, Mueller R, Greinwald R, Schoepfer A, Attwood S; International EOS-2 Study Group. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis. Gastroenterology 2020;159:1672-1685.e5. [PMID: 32721437 DOI: 10.1053/j.gastro.2020.07.039] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
25 Miret-Salvador M, Valor-Gisbert M, Ruiz-Lozano N, Gracia-Barber MD. [Eosinophilic esophagitis. A not so rare clinical case]. Semergen 2021:S1138-3593(21)00140-4. [PMID: 34147346 DOI: 10.1016/j.semerg.2021.04.012] [Reference Citation Analysis]
26 Visaggi P, Mariani L, Pardi V, Rosi EM, Pugno C, Bellini M, Zingone F, Ghisa M, Marabotto E, Giannini EG, Savarino V, Marchi S, Savarino EV, de Bortoli N. Dietary Management of Eosinophilic Esophagitis: Tailoring the Approach. Nutrients 2021;13:1630. [PMID: 34066243 DOI: 10.3390/nu13051630] [Reference Citation Analysis]